Price: mark price · perpetual futures / vs. 24h earlier / / Saved / stale
Price-discovery chart
Solid line = the referenced cash market is in session / dotted line = outside the session (overnight and weekends); both show the same perpetual-futures reference value (line styles are not distinguished at narrow display widths). About the data
Saved open interest, contract count
Saved funding rate, per-hour decimal
A medicine company.
Source: Hyperliquid · Last updated · Perpetual-futures reference value
Cash New York: 09:30–16:00. When closed: perpetual-futures reference. Hyperliquid xyz perpetual-futures reference.
How to read the chart
Reference chart of Hyperliquid perpetual-futures candles for Eli Lilly, not the official cash-market chart.
Reference value and method
How the numbers and formulas on this page work: Symbol page guide.
Eli Lilly is shown as a Hyperliquid perpetual-futures reference, and 24h compares against the previous-day reference for the same contract, not a cash price, official index, exchange close, or cash previous close.
Observed value at 2026-09-27 22:04 UTC
- Asset class
- Listed-company stock reference
- Source
- Hyperliquid / xyz:LLY
- Price unit
- USDC reference
- Reference value
- USDC 1182.50
- 24h
- +0.13%
- Method
- Use the mid price; use the mark price only when no mid price can be obtained
- Referenced contracts
- xyz:LLY
- Observed time
- Saved observation
Ratio = 1182.5 / 1181.0 − 1 = +0.13% (shown as a percentage, rounded to two decimal places).
Hyperliquid field names: mid price = midPx; mark price = markPx; previous-day reference = prevDayPx.
Fundamental figures are the values filed by the issuer in its annual report (10-K) and retrieved through the SEC EDGAR companyfacts API. No estimate or interpolation is used. Reference P/E is the only derived value that divides a Hyperliquid reference by SEC EDGAR EPS; its complete formula is printed beside the result on the symbol page.
This site does not provide investment advice.
Range position
2026-03-25 – 2026-10-08 · 198 daily candles (settled only). Daily candles are 24-hour perpetual-futures values, not official exchange closes.
- Low for this period
- USDC 851.11 (2026-04-30)
- High for this period
- USDC 1,293.9 (2026-08-19)
- Position
- 74.8%
- Reference used for position
- USDC 1182.5
- Observed at
Highs and lows after the collection period are not included.
About this symbol
One operating segment covers medicines for people. In the filing, products are listed by therapeutic area. There are four area names.
Two are Cardiometabolic Health and Oncology. The other two are Immunology and Neuroscience. About 27,000 of them were outside the United States and about 12,000 were in research and development. All of the above is from the 10-K filed 12 February 2026.
Sourced explanations (10)
Explanations may include summaries and translations. Follow the source links for the original text.
Business and products
10-K filed:
-
One operating segment covers medicines for people. In the filing, products are listed by therapeutic area. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
There are four therapeutic area names. Two are Cardiometabolic Health and Oncology, and the other two are Immunology and Neuroscience. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
Cardiometabolic Health holds Mounjaro. Zepbound and Trulicity fall under the same heading. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
The insulins Humalog and Humulin sit there too. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
Jardiance and Basaglar are marketed together with Boehringer Ingelheim. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
Oncology holds Verzenio, Jaypirca, and Retevmo. Cyramza and Erbitux belong to the same area. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
Immunology holds Taltz, Omvoh, Ebglyss, and Olumiant. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
-
Neuroscience holds Emgality and Kisunla. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
Customers and regions
10-K filed:
-
From 2023 through 2025, three customers each accounted for between 16% and 24% of revenue: McKesson, Cencora, and Cardinal Health. All three are pharmaceutical wholesalers in the United States. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
From 2023 through 2025, three customers each accounted for between 16% and 24% of revenue. They are McKesson, Cencora, and Cardinal Health. All three are pharmaceutical wholesalers in the United States. No other customer reached 10% of revenue.
Source: SEC EDGAR
People and history
10-K filed:
-
At the end of 2025 there were approximately 50,000 employees. About 27,000 were outside the United States and about 12,000 were in research and development. From the 10-K filed 12 February 2026.
Source: SEC EDGAR
The company's state of incorporation is Indiana, and its head office is in Indianapolis.
Source: SEC EDGAR
Fundamentals SEC EDGAR retrieved 2026-08-21
Source = SEC EDGAR companyfacts API, CIK 0000059478 (ELI LILLY AND COMPANY). Extraction = us-gaap tags; form 10-K; fp FY; duration 340–400 days, excluding quarters. When more than one 10-K reports the same fiscal period end, the value from the last-filed 10-K is used. Years that could not be retrieved are not drawn.
ELI LILLY AND COMPANY filings on SEC EDGAR (CIK 0000059478)
Annual revenue and net income
Axis = USD (billions) = 1,000,000,000 USD. Available annual periods = 18 (FY2008–FY2025). Revenue tag priority = RevenueFromContractWithCustomerExcludingAssessedTax → Revenues; the next tag is used only for a year missing from the prior tag. Net-income tag priority = NetIncomeLoss, under the same per-year fallback rule.
FY2008 Net income −2,071,900,000 USD, FY2017 Net income −204,100,000 USD are negative, so no bars are drawn. The exact values remain in the tables.
Latest 6 annual periods (unit USD)
| Fiscal year | Revenue | Net income | Net income / revenue |
|---|---|---|---|
| FY20202020-12-31 | 24,539,800,000 | 6,193,700,000 | 25.24% |
| FY20212021-12-31 | 28,318,400,000 | 5,581,700,000 | 19.71% |
| FY20222022-12-31 | 28,541,400,000 | 6,244,800,000 | 21.88% |
| FY20232023-12-31 | 34,124,000,000 | 5,240,000,000 | 15.36% |
| FY20242024-12-31 | 45,043,000,000 | 10,590,000,000 | 23.51% |
| FY20252025-12-31 | 65,179,000,000 | 20,640,000,000 | 31.67% |
Net income / revenue uses only the two numbers in the same row and is rounded to two decimal places.
Open all 18 available years
| Fiscal year | Revenue | Net income | Net income / revenue |
|---|---|---|---|
| FY20082008-12-31 | 20,371,900,000 | −2,071,900,000 | −10.17% |
| FY20092009-12-31 | 21,836,000,000 | 4,328,800,000 | 19.82% |
| FY20102010-12-31 | 23,076,000,000 | 5,069,500,000 | 21.97% |
| FY20112011-12-31 | 24,286,500,000 | 4,347,700,000 | 17.90% |
| FY20122012-12-31 | 22,603,400,000 | 4,088,600,000 | 18.09% |
| FY20132013-12-31 | 23,113,100,000 | 4,684,800,000 | 20.27% |
| FY20142014-12-31 | 19,615,600,000 | 2,390,500,000 | 12.19% |
| FY20152015-12-31 | 19,958,700,000 | 2,408,400,000 | 12.07% |
| FY20162016-12-31 | 21,222,100,000 | 2,737,600,000 | 12.90% |
| FY20172017-12-31 | 19,973,800,000 | −204,100,000 | −1.02% |
| FY20182018-12-31 | 21,493,300,000 | 3,232,000,000 | 15.04% |
| FY20192019-12-31 | 22,319,500,000 | 8,318,400,000 | 37.27% |
| FY20202020-12-31 | 24,539,800,000 | 6,193,700,000 | 25.24% |
| FY20212021-12-31 | 28,318,400,000 | 5,581,700,000 | 19.71% |
| FY20222022-12-31 | 28,541,400,000 | 6,244,800,000 | 21.88% |
| FY20232023-12-31 | 34,124,000,000 | 5,240,000,000 | 15.36% |
| FY20242024-12-31 | 45,043,000,000 | 10,590,000,000 | 23.51% |
| FY20252025-12-31 | 65,179,000,000 | 20,640,000,000 | 31.67% |
Annual diluted EPS (source currency per share)
Tag = EarningsPerShareDiluted. Per-share history can be restated after a stock split. From the latest 10-K, this table connects only filings whose values match exactly for every overlapping fiscal year. Displayed years = FY2008, FY2009, FY2010, FY2011, FY2012, FY2013, FY2014, FY2015, FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025 (18 years); latest filing date = 2026-02-12.
| Fiscal year | Diluted EPS | 10-K filing date |
|---|---|---|
| FY20082008-12-31 | −1.89 | 2011-02-22 |
| FY20092009-12-31 | 3.94 | 2012-02-24 |
| FY20102010-12-31 | 4.58 | 2013-02-21 |
| FY20112011-12-31 | 3.9 | 2014-02-19 |
| FY20122012-12-31 | 3.66 | 2015-02-19 |
| FY20132013-12-31 | 4.32 | 2016-02-19 |
| FY20142014-12-31 | 2.23 | 2017-02-21 |
| FY20152015-12-31 | 2.26 | 2018-02-20 |
| FY20162016-12-31 | 2.58 | 2019-02-19 |
| FY20172017-12-31 | −0.19 | 2020-02-19 |
| FY20182018-12-31 | 3.13 | 2021-02-17 |
| FY20192019-12-31 | 8.89 | 2022-02-23 |
| FY20202020-12-31 | 6.79 | 2023-02-22 |
| FY20212021-12-31 | 6.12 | 2024-02-21 |
| FY20222022-12-31 | 6.9 | 2025-02-19 |
| FY20232023-12-31 | 5.8 | 2026-02-12 |
| FY20242024-12-31 | 11.71 | 2026-02-12 |
| FY20252025-12-31 | 22.95 | 2026-02-12 |
Years whose share basis could not be matched are not placed in this table. No split ratio or backward adjustment is calculated here.
Reference P/E
Reference P/E = 1182.50 (reference at 2026-09-27 22:04 UTC) ÷ 22.95 (FY2025 diluted EPS · SEC EDGAR retrieved 2026-08-21) = 51.53 (rounded to two decimal places)
The numerator is the xyz:LLY perpetual-futures reference, not an official cash-market price. The denominator is diluted EPS reported in the issuer's annual filing. The two bases differ, so this derived value is not directly comparable with a published P/E ratio.
Market observations Retrieved: 2026-09-27 22:04 UTC
24h volume Retrieved: 2026-09-27 22:04 UTC
- Notional (USDC)
- 80,205.22
- Contracts
- 67.855
- Nominal / quantity
- 1,182.017662Notional ÷ contracts, using the values before rounding; rounded to six decimal places
Open interest (OI) Retrieved: 2026-09-27 22:04 UTC
- Open interest (contracts)
- 9,536.737
- Mark price
- 1182.4
- Notional (contracts × mark price)
- 11,276,237.59Contracts × mark price, using the values before rounding; USDC, rounded to two decimal places
Funding rate Retrieved: 2026-09-27 22:04 UTC
Funding: Hourly 0.00000625 = 0.000625% (shown as a percentage); ×24 (daily conversion) = 0.015%; ×24×365 (365-day conversion) = 5.475% (simple multiplications, not accrued amounts). The marker in the diagram shows the sign only (this value is positive).
- Hourly
- 0.00000625As a percentage: 0.000625%
- ×24 (daily conversion)
- 0.015%
- ×24×365 (365-day conversion)
- 5.475%
Hyperliquid field names and values before rounding: notional = dayNtlVlm 80205.21743 USDC; contracts = dayBaseVlm 67.8545; open interest = openInterest 9536.7368 contracts; mark price = 1182.4; hourly funding rate = funding 0.00000625.
Daily observation log (67 saved daily records) Latest: 2026-10-17 22:04:59.595 UTC
Latest: 2026-10-17 22:04:59.595 UTC · Records with missing fields: 0/67 · Missing dates: 4
Show 67 saved daily records
Hyperliquid field names: Mid price = midPx; Previous-day reference = prevDayPx; Open interest = openInterest; 24h notional volume (USDC) = dayNtlVlm. vs previous-day reference = midPx / prevDayPx - 1.
Scroll horizontally to see all columns.
| Observed at (UTC) | Mid price | Previous-day reference | vs previous-day reference | Open interest | 24h notional volume (USDC) |
|---|---|---|---|---|---|
| 1179.45 | 1184.9 | -0.46% | 2599.0058 | 278447.6638199999 | |
| 1183.8 | 1179.3 | +0.38% | 2635.1198 | 157906.39856 | |
| 1229.85 | 1184.5 | +3.83% | 4021.658 | 4548019.7819400001 | |
| 1215.1 | 1231.4 | -1.32% | 3340.6366 | 2457163.1763599999 | |
| 1220.4 | 1215.8 | +0.38% | 2933.7712 | 1598367.3574099997 | |
| 1210.45 | 1221.1 | -0.87% | 5445.2784 | 4511630.859459999 | |
| 1180.65 | 1210.2 | -2.44% | 3796.9512 | 2643316.8274699999 | |
| 1179.0 | 1180.6 | -0.14% | 3754.3012 | 560959.38879 | |
| 1184.75 | 1182.1 | +0.22% | 4152.811 | 1180380.5500299998 | |
| 1224.6 | 1184.6 | +3.38% | 4121.013 | 1811260.5487899999 | |
| 1279.95 | 1224.8 | +4.50% | 6660.4672 | 6305519.1094600018 | |
| 1246.4 | 1280.4 | -2.66% | 7662.101 | 5698810.3003999982 | |
| 1256.15 | 1246.8 | +0.75% | 6660.6386 | 2318298.5414899993 | |
| 1252.0 | 1255.8 | -0.30% | 6389.2522 | 532144.6663899999 | |
| 1254.45 | 1252.5 | +0.16% | 6346.6136 | 228736.15901 | |
| 1249.4 | 1256.5 | -0.57% | 5858.0194 | 1307251.9840499999 | |
| 1232.7 | 1248.9 | -1.30% | 5955.447 | 1030021.1548799999 | |
| 1190.8 | 1233.6 | -3.47% | 5521.6996 | 2391974.4250499988 | |
| 1176.45 | 1190.5 | -1.18% | 5367.647 | 1507560.9333899994 | |
| 1172.05 | 1176.3 | -0.36% | 5266.6694 | 952679.12018 | |
| 1171.75 | 1172.7 | -0.08% | 5176.1758 | 171409.8302800001 | |
| 1173.95 | 1171.8 | +0.18% | 5273.9198 | 157373.21748 | |
| 1160.2 | 1175.1 | -1.27% | 5123.6572 | 959806.1134199998 | |
| 1160.65 | 1160.4 | +0.02% | 5133.9412 | 578569.5631 | |
| 1162.3 | 1160.1 | +0.19% | 5022.0926 | 326288.1753 | |
| 1160.55 | 1162.4 | -0.16% | 5091.6372 | 279203.52958 | |
| 1146.5 | 1161.0 | -1.25% | 5320.4842 | 721819.97708 | |
| 1153.05 | 1148.0 | +0.44% | 5494.6098 | 346343.6734600001 | |
| 1152.25 | 1152.9 | -0.06% | 5578.075 | 210028.64679 | |
| 1125.25 | 1127.8 | -0.23% | 5588.2642 | 378778.078 | |
| 1124.3 | 1125.2 | -0.08% | 5711.6332 | 622485.3781499999 | |
| 1116.5 | 1124.7 | -0.73% | 5758.7602 | 561455.9768299999 | |
| 1117.9 | 1116.0 | +0.17% | 5739.2578 | 111271.07955 | |
| 1138.5 | 1114.6 | +2.14% | 7655.0362 | 2395406.5448499997 | |
| 1137.25 | 1139.0 | -0.15% | 7537.1108 | 1042944.6737399998 | |
| 1137.4 | 1137.3 | +0.01% | 7510.7162 | 488332.1217200001 | |
| 1152.25 | 1137.7 | +1.28% | 7486.508 | 626831.4285899999 | |
| 1154.55 | 1151.8 | +0.24% | 7468.0268 | 858381.7110999998 | |
| 1153.55 | 1153.6 | 0.00% | 7500.0766 | 176518.37178 | |
| 1154.25 | 1153.6 | +0.06% | 7546.902 | 62817.60116 | |
| 1165.25 | 1153.3 | +1.04% | 7411.4778 | 1135160.5824400003 | |
| 1172.75 | 1166.4 | +0.54% | 7749.6176 | 1269299.9330499994 | |
| 1153.25 | 1174.1 | -1.78% | 8327.4574 | 1441205.3147499999 | |
| 1185.15 | 1153.7 | +2.73% | 9296.116 | 2490017.471309999 | |
| 1184.4 | 1185.0 | -0.05% | 9527.773 | 898277.8864800001 | |
| 1181.45 | 1185.1 | -0.31% | 9508.497 | 84359.84732 | |
| 1182.5 | 1181.0 | +0.13% | 9536.7368 | 80205.21743 | |
| 1186.95 | 1182.9 | +0.34% | 9341.5966 | 4461956.8126100004 | |
| 1184.6 | 1187.1 | -0.21% | 9248.5632 | 659592.26357 | |
| 1162.95 | 1184.5 | -1.82% | 8526.4412 | 2625987.9152199998 | |
| 1151.5 | 1163.1 | -1.00% | 8190.321 | 1519945.5867100004 | |
| 1143.05 | 1151.4 | -0.73% | 5817.9388 | 4125987.8075299985 | |
| 1142.9 | 1143.5 | -0.05% | 5834.2126 | 114780.21651 | |
| 1146.9 | 1143.0 | +0.34% | 5849.713 | 77371.57958 | |
| 1146.35 | 1147.3 | -0.08% | 5339.3584 | 964311.0959400005 | |
| 1159.0 | 1146.0 | +1.13% | 4781.1236 | 1324332.7674499997 | |
| 1188.45 | 1158.9 | +2.55% | 4282.9006 | 1646196.8890799994 | |
| 1168.3 | 1190.0 | -1.82% | 4459.7948 | 1489221.27556 | |
| 1177.3 | 1167.5 | +0.84% | 4248.8848 | 756180.4812699998 | |
| 1176.75 | 1176.9 | -0.01% | 4223.761 | 36814.19219 | |
| 1176.2 | 1177.9 | -0.14% | 4176.771 | 159978.42184 | |
| 1181.55 | 1175.8 | +0.49% | 4119.2882 | 570133.97244 | |
| 1167.5 | 1181.5 | -1.18% | 4038.6558 | 536179.6068199995 | |
| 1209.55 | 1167.6 | +3.59% | 3666.4262 | 1382889.8494999993 | |
| 1252.9 | 1209.8 | +3.56% | 3964.5904 | 2296445.2379800002 | |
| 1257.9 | 1252.7 | +0.42% | 3563.234 | 1591347.44713 | |
| 1255.75 | 1258.2 | -0.19% | 3541.6198 | 187525.87587 |
Dates without a saved record in the displayed period: 2026-08-16, 2026-09-07, 2026-09-08, 2026-09-13.
Period range (67 records with a mid price)
Period range over 67 daily log rows: first mid price 1179.45; last mid price 1255.75; highest mid price in the period 1279.95; lowest mid price in the period 1116.5.
- First mid price2026-08-08 22:05:00.098 UTC
- 1179.45
- Last mid price2026-10-17 22:04:59.595 UTC
- 1255.75
- Highest mid price in the period2026-08-19 22:05:01.242 UTC
- 1279.95
- Lowest mid price in the period2026-09-11 22:04:47.849 UTC
- 1116.5
Market hours
| Trading hours | New York time 09:30-16:00 |
|---|---|
| Days | Weekdays. Check the related venue calendar for holidays. |
Other symbols in this group
Related articles
Frequently asked questions
What are Eli Lilly's annual revenue and net income?
The latest available annual filing (10-K) reports FY2025 ending 2025-12-31: revenue 65,179,000,000 USD and net income 20,640,000,000 USD. The figures were retrieved from SEC EDGAR on 2026-08-21. A missing figure is omitted rather than estimated.
How is the reference P/E for Eli Lilly calculated?
The live xyz:LLY perpetual-futures reference is divided by FY2025 diluted EPS of USD 22.95 per share, then rounded to two decimal places. The exact numerator, denominator, retrieval time, and result are printed in the Reference P/E formula. The reference is not an official cash-market price, so its basis differs from a published P/E ratio.
Are the Eli Lilly chart and the figures below the same data?
No. The chart and Market observations use the live Hyperliquid perpetual-futures response. Fundamentals use annual figures filed with the SEC and retrieved on 2026-08-21. Only the Reference P/E combines the two, and its formula is printed beside the value.